✦ LIBER ✦

Strategy for the borderline resectable pancreatic cancer using neo-adjuvant chemoradiation therapy

✍ Scribed by Hatori, Takashi; Suzuki, Shuji; Ooshima, Nana; Suzuki, Ryuji; Kimijima, Akira; Izumo, Wataru; Furukawa, Toru; Mitsuhashi, Norio; Shiratori, Keiko; Yamamoto, Masakazu

Book ID: 122155147
Publisher: S. Karger AG
Year: 2013
Tongue: English
Weight: 43 KB
Volume: 13
Category: Article
ISSN: 1424-3903
DOI: 10.1016/j.pan.2013.07.087

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neo-adjuvant Chemoradiation Therapy Usin

Neo-adjuvant Chemoradiation Therapy Using S-1 Followed by Surgical Resection in Patients with Pancreatic Cancer

✍ Sohei Satoi; Hideyoshi Toyokawa; Hiroaki Yanagimoto; Tomohisa Yamamoto; Minoru K 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 215 KB

Appraisal for neoadjuvant chemoradiation

Appraisal for neoadjuvant chemoradiation therapy in borderline resectable pancreatic cancer; special reference to isolated venous vascular involvement

✍ Lee, Jin Ho; Kang, Chang Moo 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 298 KB

Is CA19-9 Response Following Chemoradiat

Is CA19-9 Response Following Chemoradiation Therapy for Borderline Resectable Pancreatic Cancer an Early Surrogate for Eventual Survival Outcomes?

✍ Krishnan, S.; Ahmad, M.; Noguera Gonzalez, G.; Das, P.; Minsky, B.; Delclos, M.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Strength of the Evidence: Adjuvant Thera

Strength of the Evidence: Adjuvant Therapy for Resected Pancreatic Cancer

✍ Vincent J. Picozzi; Peter W. T. Pisters; Selwyn M. Vickers; Steven M. Strasberg 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 93 KB

The influence of MDT meetings on use of

The influence of MDT meetings on use of neo-adjuvant therapy, cancer recurrence and surgical resection rates for rectal cancer

✍ Bettina Lieske; R. Robertson; J. Gildersleve; R. Farouk 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 41 KB

The case for routine use of adjuvant the

The case for routine use of adjuvant therapy in pancreatic cancer

✍ Eugene P. Kennedy; Charles J. Yeo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

## Abstract Pancreatic cancer is a devastating disease with a poor prognosis for most patients. Surgical resection remains the cornerstone of treatment, providing the only realistic hope of long‐term survival. Even with optimal surgical management, 5‐year survival averages 15% to 20% for resectable